The U.S. Food and Drug Administration (FDA) has approved Journavx, the first opioid-free prescription drug for moderate to ...

A new report released by an anti-transnational crime group has identified the core chemical components of kush, a synthetic ...

The FDA has approved label changes for once-monthly Sublocade, helping to reduce possible barriers to treatment initiation ...

West Virginia has the highest opioid overdose mortality rate in the country, and leaders are bringing new legislation into ...

Nearly 87,000 Americans died from drug overdose in the United States in the 12-month period ending September 2024, a decline of about 24% from the previous year, according to preliminary data from the ...

In looking at the profound impact on satiety that GLP-1s have, Penn State College of Medicine Drs. Patrician Grigson and ...

On January 30, the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid ...

The US FDA has approved Journavx, a new pain reliever without the risks for addiction or overdose linked to drugs like Vicodin and OxyContin.

Indivior said the U.S. Food and Drug Administration approved label changes for its opioid-dependence treatment Sublocade, including a rapid initiation protocol and alternative injection sites.

Rates of drug overdose deaths decreased in the U.S. for the first time since the pandemic began, according to new federal ...

Palghar: The Union health ministry has stopped operations and production of Aveo Pharmaceuticals Ltd. (Aveo) following ...

America’s opioid crisis is showing signs of subsiding, a new report from the U.S. Centers for Disease Control and Prev ...